POLYVINYL-ALCOHOL AS A DEFINED SUBSTITUTE FOR SERUM IN VITRIFICATION AND WARMING SOLUTIONS TO CRYOPRESERVE OVINE EMBRYOS AT DIFFERENT STAGES OF DEVELOPMENT
S. Naitana et al., POLYVINYL-ALCOHOL AS A DEFINED SUBSTITUTE FOR SERUM IN VITRIFICATION AND WARMING SOLUTIONS TO CRYOPRESERVE OVINE EMBRYOS AT DIFFERENT STAGES OF DEVELOPMENT, Animal reproduction science, 48(2-4), 1997, pp. 247-256
The purpose of this study was to assess the viability of ovine embryos
after replacing fetal calf serum (FCS) with polyvinyl alcohol (PVA) i
n vitrification and warming solutions. Ovine embryos were obtained fro
m superovulated Sardinian breed ewes at 4, 5, 6, and 7 days after inse
mination. All vitrification and warming solutions were prepared using
buffered saline solution with 20% FCS (group a) or 0.1% PVA (group b).
Embryos were vitrified in 20 mu l of glycerol 3.4 M + ethylene glycol
4.6 M and loaded into the centre of 0.25 mi straws between two column
s of sucrose solution (0.5 M), and plunged immediately into liquid nit
rogen. After being warmed in a water bath at 35 degrees C for 10 s, th
e vitrified embryos were moved to 0.25 M sucrose solution for 3 min. E
mbryos were cultured in TCM-199 after washing with 10% FCS and sheep o
viductal epithelial cells up to hatching or re-expansion of the blasto
coelic cavity. No significant difference in the viability rates was ob
served between embryos vitrified/warmed in PVA or FCS solutions. In bo
th groups, the rate of in vitro viability was (P < 0.01) lower at the
precompacted and compacted morula stages than at the expanded, hatchin
g or hatched blastocyst stage. In both groups, early blastocysts were
less viable than expanded (P<0.01), hatching or hatched blastocyst (P
< 0.05). There was no significant difference in survival rates at days
14 (79 and 76%) and 45 (63 and 59%) after transfer into synchronised
recipients between vitrified expanded blastocysts of groups a and b, r
espectively. These results suggest that it is possible replace serum w
ith PVA in vitrification and warming solutions without reducing in viv
o and in vitro viability. (C) 1997 Elsevier Science B.V.